CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
5.93
+0.59 (11.05%)
Jan 27, 2026, 4:00 PM EST - Market closed
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $1 billion as of January 27, 2026. Its market cap has increased by 1,358.28% in one year.
Market Cap
1.00B
Enterprise Value
866.72M
1-Year Change
1,358.28%
Ranking
Category
Stock Price
$5.93
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $1.00B, an increase of 13,477.73%. That is a compound annual growth rate of 61.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 1.00B | 39.21% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 992.71M |
| UroGen Pharma | 986.73M |
| ArriVent BioPharma | 974.24M |
| Maravai LifeSciences Holdings | 946.12M |
| Xencor | 929.76M |
| Bicara Therapeutics | 899.52M |
| Janux Therapeutics | 880.56M |
| Geron | 874.55M |